by Ariana | Jan 15, 2025 | Article
NOTICE IS HEREBY GIVEN, that Lupus Canada will host its 2025 Annual General Meeting on Monday February 24th, 2025 at 8:30pm EST via Zoom. Lupus Canada is inviting you to a scheduled Zoom meeting. Topic: Lupus Canada AGMTime: Feb 24, 2025 08:30 PM Eastern Time (US and...
by Ariana | Dec 3, 2024 | Article
Introducing Lupus Canada’s Advocacy Toolkit for Individuals Empowering the lupus community to create meaningful change through advocacy. Discover Lupus Canada’s Advocacy Toolkit for Individuals—a comprehensive resource designed to empower lupus patients, caregivers,...
by Ariana | Sep 17, 2024 | Article
What is a biologic? A biologic is a pharmaceutical drug product or vaccine manufactured in, extracted from, or synthesized from biological sources. www.canada.ca/en/health-canada/services/drugs-health-products/biologics What’s the difference between a biologic...
by Cora Novacut-Lee | Jul 12, 2024 | Article
Exciting Breakthrough in Lupus Research!Scientists at Northwestern Medicine and Brigham and Women’s Hospital have potentially uncovered a root cause of lupus, Dr. Deepak Rao states, “This could explain the vast majority of lupus cases.” This discovery...
by Ariana | Jun 27, 2024 | Article
We are pleased to announce that Belimumab (Benlysta), a prescription drug used to treat adults with lupus-related kidney inflammation (active lupus nephritis), has been included in the Exception Drug Status (EDS) Benefit of the Saskatchewan and Nova Scotia Formularies...
